| Entry |
|
|---|
| Name |
Clocapramine (INN)
|
|---|
| Formula |
C28H37ClN4O
|
|---|
| Exact mass |
480.2656
|
|---|
| Mol weight |
481.0726
|
|---|
| Structure |
     |
|---|
| Activity |
Neuroleptic
|
|---|
| Comment |
Iminodibenzyl derivatives
|
|---|
| Target |
dopamine D2-receptor antagonist [HSA: 1813] [KO: K04145] |
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Structure map |
| Dopamine receptor agonists/antagonists |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Dopamine
dopamine D2-receptor [HSA:1813] [KO:K04145]
Clocapramine
D07718 Clocapramine (INN)
 |
|---|
| Other DBs |
CAS: 47739-98-0 PubChem: LigandBox: NIKKAJI: |
|---|
| KCF data |
ATOM 34
1 C1x C 21.2100 -22.4700
2 C8y C 20.3700 -21.3500
3 C8y C 20.7200 -20.0200
4 N1y N 21.9800 -19.4600
5 C1x C 22.6100 -22.4700
6 C8y C 23.2400 -20.0900
7 C8y C 23.5200 -21.4200
8 C8x C 19.6700 -19.0400
9 C8x C 18.3400 -19.4600
10 C8y C 17.9900 -20.7900
11 C8x C 19.0400 -21.7700
12 C8x C 24.7800 -21.8400
13 C8x C 25.8300 -20.9300
14 C8x C 25.5500 -19.5300
15 C8x C 24.2200 -19.1100
16 X Cl 16.6600 -21.2100
17 C1b C 21.9800 -18.0600
18 C1b C 23.1700 -17.4300
19 C1b C 24.4300 -18.1300
20 N1y N 25.6200 -17.5000
21 C1x C 26.8100 -18.2000
22 C1x C 28.0700 -17.5700
23 C1z C 28.0700 -16.1700
24 C1x C 26.8800 -15.4700
25 C1x C 25.6200 -16.1000
26 N1y N 29.2600 -15.5400
27 C1x C 30.4500 -16.2400
28 C1x C 31.6400 -15.5400
29 C1x C 31.6400 -14.2100
30 C1x C 30.5200 -13.4400
31 C1x C 29.2600 -14.1400
32 C5a C 29.4000 -17.5000
33 N1a N 30.5900 -16.8700
34 O5a O 29.4000 -18.9000
BOND 38
1 3 4 1
2 1 5 1
3 4 6 1
4 2 3 1
5 5 7 1
6 1 2 1
7 6 7 1
8 3 8 2
9 8 9 1
10 9 10 2
11 10 11 1
12 2 11 2
13 7 12 2
14 12 13 1
15 13 14 2
16 14 15 1
17 6 15 2
18 10 16 1
19 4 17 1
20 17 18 1
21 18 19 1
22 19 20 1
23 20 21 1
24 21 22 1
25 22 23 1
26 23 24 1
27 24 25 1
28 20 25 1
29 23 26 1
30 26 27 1
31 27 28 1
32 28 29 1
33 29 30 1
34 30 31 1
35 26 31 1
36 23 32 1
37 32 33 1
38 32 34 2
|
|---|
